CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Name: CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Published: 2016
License: Public Domain

Anthera Pharmaceuticals · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

autoimmune-diseases sle systemic systemic-lupus-erythematosus

systemic lupus erythematosus, sle, lupus, lupus erythematosus, systemic, autoimmune diseases, a-623, blisibimod, nephritis, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Related documents